Liraglutide Dosage Chart Olympia Pharmaceuticals Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. The Peptide Craze Ground Truths FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives